APOE and Alzheimer disease: Nonetheless, despite its strong genetic association with AD, clinical trials for disease-modifying treatments targeting the amyloid cascade pathway and focusing on carriers of ApoE ε4 did not yield successful results yet (Yiannopoulou et al., 2019; Serrano-Pozo et al., 2021).